Study Stopped
Collaborators did not enter patients into the study
A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent atrial fibrillation over time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2005
Longer than P75 for not_applicable atrial-fibrillation
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedMarch 20, 2015
March 1, 2015
5 years
September 13, 2005
March 18, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of patients in sinus rhythm after 3, 6, and 12 months
3, 6,
Number of patients with atrial function at echo-doppler after 6 and 12 months
3,6, 12 months
Number of patients on anticoagulants after 6 and 12 months
6 and 12 months
Study Arms (1)
Bipolar radiofrequency ablation
EXPERIMENTALInterventions
Ablation using CE marked bipolar ablation devices
Eligibility Criteria
You may qualify if:
- referred for elective heart surgery with extracorporeal circulation
- suffers from AF for more than 6 months but less than 7 years
- aged between 18 and 80 years
- ejection fraction above 30 %
You may not qualify if:
- Reoperations
- NYHA class IV
- Ischemic mitral incompetence
- Creatinine \> 140
- Transmural myocardial infarction \< 4 weeks
- Endocarditis
- Serious peripheral vascular disease
- Pregnancy or breast-feeding
- Drug addiction
- Size of left atrium \> 60 mm in preoperative echo-doppler investigation.
- Disease or other condition when the patient is unable to understand the objectives and the scope of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- Oslo University Hospitalcollaborator
- Haukeland Sykehus HFcollaborator
- Ullevaal University Hospitalcollaborator
- Regionssykehuset i Tromsø HFcollaborator
- Feiringklinikkencollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Alexander Wahba, Prof
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 16, 2005
Study Start
June 1, 2005
Primary Completion
June 1, 2010
Study Completion
June 1, 2012
Last Updated
March 20, 2015
Record last verified: 2015-03